ログイン
ランキング
お知らせ
ログイン
文献詳細
特集 泌尿器科医のためのクリニカル・パール（1）
文献概要
要旨 腎癌の臨床では，決断を必要とする場面に多々遭遇する。その際には必ずしもエビデンスで裏打ちされたものだけではなく，経験に基づいた秘訣なども駆使する必要がある。この経験に基づく助言（クリニカル・パール）は，特に若い医師が上級医から受け継ぐものである。われわれの2,000例近い手術症例，400例を超える薬物治療の経験から学んだ秘訣を，診断，外科手術，薬物治療から7つ紹介する。
参考文献
1）Novick AC, Campbell SC, Belldegrun A, et al：Guideline for Management of the Clinical Stage 1 Renal Mass. American Urological Association Education and Research, Linthicum, 2009
2）日本泌尿器科学会：腎癌診療ガイドライン．金原出版，東京，2011
3）Ljungberg B, Bensalah K, Bex A, et al：Guidelines on renal cell carcinoma. European Association of Urology, Arnhem, 2013
）. Version 1, 2014
5）篠崎賢治：腎癌の診断/腎腫瘍の画像診断 超音波検査．In：田邉一成（編）：腎癌のすべて−基礎から実地診療まで 改訂第2版．メジカルビュー社，東京pp83-86，2014
6）Forman HP, Middleton WD, Melson GL, et al：Hyperechoic renal cell carcinomas：increase in detection at US. Radiology 188：431-434, 1993
7）Yamashita Y, Ueno S, Makita O, et al：Hyperechoic renal tumors：anechoic rim and intratumoral cysts in US differentiation of renal cell carcinoma from angiomyolipoma. Radiology 188：179-182, 1993
8）Siegel CL, Middleton WD, Teefey SA, et al：Angiomyolipoma and renal cell carcinoma：US differentiation. Radiology 198：789-793, 1996
9）Ascenti G, Zimbaro G, Mazziotti S, et al：Usefulness of power Doppler and contrast-enhanced sonography in the differentiation of hyperechoic renal masses. Abdom imaging 26：654-660, 2001
10）木村 健：腎癌の診断/腎腫瘍の画像診断 CT．In：田邉一成（編）：腎癌のすべて−基礎から実地診療まで 改訂第2版．メジカルビュー社，東京，pp87-91，2014
11）Tsivian M, Moreira DM, Caso JR, et al：Predicting occult multifocality of renal cell carcinoma. Eur Urol 58：118-126, 2010
12）Simhan J, Canter DJ, Sterious SN, et al：Pathological concordance and surgical outcomes of sporadic synchronous unilateral multifocal renal masses treated with partial nephrectomy. J Urol 189：43-47, 2013
13）Tsivian M, Rampersaud EN Jr, Laguna MP, et al：Small renal mass biopsy-how, what and when：report from an international consensus panel. BJU Int 112：526-530, 2013
14）Volpe A, Finelli A, Gill IS, et al：Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol 62：491-504, 2012
15）Sun M, Abdollah F, Bianchi M, et al：Treatment Management of Small Renal Masses in the 21st Century：A Paradigm Shift. Ann Surg Oncol 9：2380-2387, 2012
16）Leveridge MJ, Finelli A, Kachura JR, et al：Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur Urol 60：578-584, 2011
17）Herts BR and Baker ME：The current role of percutaneous biopsy in the evaluation of renal masses. Semin Urol Oncol 13：254-261, 1995
18）Fujii Y, Komai Y, Saito K, et al：Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses：Japanese dual-center experience with 176 consecutive patients. Urology 72：598-602, 2008
19）Silverman SG, Mortele KJ, Tuncali K, et al：Hyperattenuating renal masses：etiologies, pathogenesis, and imaging evaluation. Radiographics 27：1131-1143, 2007
20）Gill IS, Patil MB, Abreu AL, et al：Zero ischemia anatomical partial nephrectomy：a novel approach. J Urol 187：807-814, 2012
21）Novick AC, editor. Partial nephrectomy. 2nd ed. WB Saunders, Philadelphia, 1998
22）Gohji K, Hara I, Gotoh A, et al：Multifocal renal cell carcinoma in Japanese patients with tumors with maximal diameters of 50 mm or less. J Urol 159：1144-1147, 1998
23）Zucchi A, Mearini L, Mearini E, et al：Renal cell carcinoma：histological findings on surgical margins after nephron sparing surgery. J Urol 169：905-908, 2003
24）Campbell SC and Lane BR：Malignant renal tumors. In：Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology, 10th ed. Saunders, New York, pp1413-1474, 2012
25）Castilla EA, Liou LS, Abrahams NA, et al：Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma. Urology 60：993-997, 2002
26）Minervini A, Ficarra V, Rocco F, et al：Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma：results of a nonrandomized, retrospective, comparative study. J Urol 185：1604-1610, 2011
27）Bensalah K, Pantuck AJ, Rioux-Leclercq N, et al：Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 57：466-471, 2010
28）Alt AL, Boorjian SA, Lohse CM, at al：Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer 117：2873-2882, 2011
29）Naito S, Kinoshita H, Kondo T, et al：Prognostic factors of patients with metastatic renal cell carcinoma with removed metastases：a multicenter study of 556 patients. Urology 82：846-851, 2013
30）Tosco L, Van Poppel H, Frea B, et al：Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. Eur Urol 63：646-652, 2013
31）バイエル薬品工業：ネクサバール適正使用ガイド．2009
32）ファイザー製薬：スーテント適性使用ガイド．2009
33）Kondo T, Takagi T, Kobayashi H, et al：Superior Tolerability of Altered Dosing Schedule of Sunitinib with 2-Weeks-on and 1-Week-off in Patients with Metastatic Renal Cell Carcinoma--Comparison to Standard Dosing Schedule of 4-Weeks-on and 2-Weeks-off. Jpn J Clin Oncol 44：270-277, 2014
掲載誌情報
